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Condensation sentence 
Dual survival after equatorial laser for TTTS was lower in the presence of abnormal 
donor umbilical artery Doppler due to an increased intrauterine mortality of donor 
twins. 
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Abstract 
Background: Endoscopic laser coagulation of placental anastomoses is the first-line 
treatment for severe twin-to-twin transfusion syndrome (TTTS). A recent randomized 
controlled trial reported that laser coagulation along the entire vascular equator was 
associated with a similar dual survival and survival of at least one twin compared to 
the group treated with the selective technique. In addition, there was a significantly 
lower incidence of postoperative recurrence of TTTS and development of twin 
anemia-polycytemia sequence (TAPS) in the equatorial group. 
Objective: To report on neonatal survival in TTTS pregnancies treated with 
endoscopic laser using the equatorial technique and to examine the relationship 
between preoperative factors and twin loss. 
Study design: Endoscopic equatorial laser was carried out as the primary treatment 
for TTTS in all consecutive monochorionic diamniotic twin pregnancies referred at a 
single fetal surgery Centre over a 4 years’ period. All visible placental anastomoses 
were coagulated and additional laser ablation of the placental tissue between the 
coagulated vessels was carried out. Pre-laser ultrasound data, peri-procedural 
complications, pregnancy outcome and postnatal survival at hospital discharge were 
recorded and analysed.  
Results: A total of 106 pregnancies were treated during the study period. Median 
gestational age at laser was 19.7 (range 15.1-27.6) weeks. There was postoperative 
recurrence of TTTS or development of TAPS in 2 (1.9%) and 2 (1.9%) cases, 
respectively. The survival rates of both and at least one twin were 56.6% and 83.0%, 
respectively. Donor survival was significantly lower compared to the recipient co-twin 
(64.2% vs 75.5%, respectively; p<0.05). The rate of fetal death, which was the most 
common cause of twin loss, was significantly higher in donors compared to recipient 
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fetuses (23.6% vs 10.4%, respectively; p<0.05). In cases with absent or reversed 
end-diastolic velocity in the donor umbilical artery, dual and donor survival rates were 
significantly lower compared to the remaining TTTS pregnancies (40.0% vs 64.8% 
and 40.0% vs 76.1%, respectively; p<0.05). There were no significant differences 
between the two groups in the survival of at least one twin and in the recipient 
survival. 
Conclusions: Endoscopic equatorial laser was associated with a survival of both and 
at least one twin of about 55% and 83%, respectively, and with a low rate of recurrent 
TTTS and TAPS. In addition, the preoperative finding of abnormal donor umbilical 
artery Doppler identified a subgroup of TTTS pregnancies with a lower dual survival 
rate due to increased intrauterine mortality of donor twins. 
 
 
Key words: monochorionic twins, twin-to-twin transfusion syndrome, equatorial 
laser, survival, Doppler 
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Introduction 
Endoscopic laser coagulation of placental anastomoses is the first-line treatment for 
severe twin-to-twin transfusion syndrome1 (TTTS), which affects 10-15% of 
monochorionic diamniotic twin pregnancies. Most of the studies examining the effects 
of laser therapy on postnatal survival have used the selective technique, by which 
only visible anastomoses are coagulated2-10. Additional laser ablation of the placental 
tissue between the anastomoses along the vascular equator has been proposed11 to 
achieve a complete coagulation of all non-visible vascular connections between the 
two placental territories.  
Only few studies have examined pregnancy and neonatal outcomes using equatorial 
laser for the treatment of TTTS12-16. A recent randomized controlled trial has shown 
that this approach, also called ‘Solomon’ technique, was associated with a similar 
dual survival and survival of at least one twin compared to the group treated with the 
selective technique. In addition, there was a significantly lower incidence of 
postoperative recurrence of TTTS and development of twin anemia-polycytemia 
sequence (TAPS) in the equatorial group15.  
The aim of this study is to report on neonatal survival in TTTS pregnancies treated 
with endoscopic equatorial laser and to examine the relationship between 
preoperative factors and twin loss. 
 
Methods 
Endoscopic equatorial laser was carried out as the primary treatment for TTTS in all 
consecutive monochorionic diamniotic twin pregnancies referred at a single fetal 
surgery Centre in Italy over a 4 years’ period (2011-2014).  
6 
 
 
 
In all cases, a detailed ultrasound examination (RAB 4-8 transducer, Voluson E8, GE 
Medical Systems, Milwaukee, WI, USA) was performed within 48 hours before laser 
treatment. The minimum required criteria for the diagnosis of TTTS were 
oligohydramnios in the sac of the donor, defined as a maximum vertical pocket of 
amniotic fluid of < 2 cm, and polyhydramnios in the sac of the recipient twin, defined 
as a maximum vertical pocket of > 8 cm before 20 weeks’ gestation and > 10 cm 
thereafter. The estimated fetal weight was derived from the appropriate reference 
ranges for gestation17,18 and the inter-twin discordance in estimated fetal weight was 
calculated as the weight difference divided by the weight of the large twin. Doppler 
assessments of the umbilical arteries and the ductus venosus of both twins were 
carried out in all cases. 
Endoscopic laser surgery was performed using a semi-rigid 2.0-mm diameter 
fetoscope (Karl Storz GmbH, Tuttlingen, Germany) through a 3.3-mm diameter 
cannula (Cook Medical, Bloomington, Ind., USA), which was introduced 
transabdominally into the sac of the recipient twin after the administration of 
prophylactic antibiotics and local anaesthesia. A 400-μm diameter diode laser fibre 
(Dornier Med Tech, Wessling, Germany) with a power output of 20-30 W was used 
for coagulation of the placental surface. All visible inter-twin vascular anastomoses 
were coagulated with additional laser ablation of the placental tissue between the 
coagulated vessels, as previously described11. Subsequently, amnioreduction of the 
polyhydramnios was undertaken through the cannula over a period of 10–15 min to 
obtain subjective normalisation of the amniotic fluid volume on ultrasonographic 
examination. All patients underwent a period of observation in the hospital of about 
48 hours. Weekly follow-up was undertaken at our Centre for the first 4 weeks 
postoperatively and at the referring hospitals thereafter.  
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Maternal demographic characteristics, ultrasound findings and details of intrauterine 
intervention were recorded in a database. Pregnancy outcome and neonatal survival 
at hospital discharge were collected when they became available from the referring 
hospitals or from the patients. 
The study did not require formal ethical approval as data collection did not alter 
clinical management or standard of care and information on postnatal outcome is 
routinely recorded for each case undergoing intrauterine treatment at our Centre. 
Informed consent to the use of confidential information according to the Hospital 
privacy policy was obtained for each patient. 
 
Statistical analysis 
Comparisons in the examined parameters between different groups were performed 
using the Chi-square test or Fisher’s exact test for categorical variables and the 
Mann-Whitney U test for continuous variables. The tests were considered significant 
at a p value of <0.05 using two-tailed tests. 
Logistic regression analysis was used to determine the variables providing a 
significant contribution in predicting postnatal twin survival. Univariate analysis was 
carried out to examine the individual variables contributing to survival by assessing 
their odds ratios and 95% confidence intervals. Subsequently, multivariate logistic 
regression analysis with backward stepwise elimination was performed to determine 
which of these variables provide a significant independent contribution in the logistic 
model.  
The data were analysed using the statistical software package IBM SPSS 19.0 (IBM 
Corp., Armonk, N.Y., USA) and Excel for Windows 2010 (Microsoft Corp., Redmond, 
WA, USA). 
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Results 
Endoscopic equatorial laser was carried out at our Centre in 106 cases of TTTS 
during the study period. Table 1 shows the main obstetric and fetal characteristics of 
the study population. Complications within 14 days postoperatively included preterm 
premature rupture of membranes (p-PROM) in 4 (3.8%) cases, preterm labor in 5 
(4.7%) and maternal bleeding in 3 (2.8%) cases. In 1 (0.9%) patient, bleeding at the 
site of trocar entry required maternal blood transfusion, with no further complications. 
In 2 (1.9%) cases, there was recurrence of TTTS which was treated with repeat laser. 
In additional 2 (1.9%) pregnancies, there was development of TAPS that was treated 
with fetal blood transfusion of the anemic twin. 
Details on pregnancy outcome and neonatal survival are shown in Table 2. The 
survival rates of both and at least one twin at neonatal hospital discharge were 
56.6% and 83.0%, respectively. Donor survival was significantly lower compared to 
the recipient co-twin (64.2% vs 75.5%, respectively; p<0.05). The prevalence of fetal 
death, which was the most common cause of twin loss, was significantly higher in 
donors compared to recipient fetuses (23.6% vs 10.4%, respectively; p<0.05).  
Preoperative findings in survivors, compared to cases with fetal or neonatal death, 
are shown in Table 3. In donor fetuses that died there was a significantly higher 
prevalence of estimated fetal weight discordance with the co-twin > 25% and 
abnormal umbilical artery Doppler. No difference in the examined parameters was 
observed in recipient twins according to postnatal survival. 
Donor survival was significantly lower in Quintero stage III cases compared to stage I 
and II (47.1% vs 85.2% and 47.1% vs 74.1%, respectively; p<0.05), with no 
difference between stage I and II pregnancies (p=0.501). No significant difference in 
recipient survival was observed according to Quintero stages. 
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Logistic regression analysis demonstrated that significant predictors of donor survival 
were estimated fetal weight discordance > 25% and absent or reversed end-diastolic 
velocity in the umbilical artery. In the multivariate analysis, the only independent 
contribution to donor survival was provided by abnormal umbilical artery Doppler 
(Table 4). 
Table 5 shows the differences in preoperative factors, fetal and neonatal outcome 
between TTTS cases with absent or reversed end diastolic velocity in the umbilical 
artery of the donor (Group A) and the remainder pregnancies (Group B). Dual and 
donor survival rates were significantly lower in Group A compared to Group B (40.0% 
vs 64.8% and 40.0% vs 76.1%, respectively; p<0.05). There were no significant 
differences between the two groups in the survival of at least one twin and in the 
recipient survival. 
 
Discussion 
This study shows that, in our experience, equatorial laser was associated with a 
survival of both and at least one twin of about 55% and 83%, respectively, and with a 
low rate of recurrent TTTS and TAPS. In addition, the preoperative finding of 
abnormal donor umbilical artery Doppler identified a subgroup of TTTS pregnancies 
with a lower dual survival rate due to increased intrauterine mortality of donor twins. 
Recent studies on treatment of TTTS using the equatorial laser technique reported 
survival rates of both and at least one twin ranging between 64% and 85% and 
between 84% and 91%, respectively12-16. A recent randomised controlled trial 
showed no significant difference in postnatal survival after equatorial laser compared 
to the more widely used selective approach15. In contrast, observational studies 
reported a trend towards a higher dual survival rate using equatorial laser, with a 
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similar survival of at least one twin between the two techniques12,13. A review of 
studies comparing equatorial and selective laser suggested an overall improved 
survival with equatorial laser, but addressed the need for an appropriately powered 
randomised controlled trial in order to confirm these results and to assess the impact 
of laser technique on long-term neurological morbidity19. However, it will be difficult 
for such a study to be carried out because the recently published randomised trial 
showed significant benefits of equatorial laser, with no disadvantages in terms of 
survival compared to the selective technique, on the rate of postoperative 
complications such as recurrence of TTTS and TAPS15. 
The survival rate of donor twins in our cohort was about 10% lower than that of the 
recipients and this has been previously reported20. The most common cause of twin 
loss in our study was spontaneous intrauterine death, which accounted for about 
60% of all losses and was significantly more common in donor fetuses (Table 2). 
Among the preoperative factors included in our protocol, donor survival was 
significantly associated with the presence or absence of severe inter-twin fetal weight 
discordance and abnormal umbilical artery Doppler. However, in the multivariate 
analysis the only independent contribution to donor survival was provided by absent 
or reversed end-diastolic velocity in the umbilical artery and these results are 
consistent with previous studies using the selective laser technique6-9. Donor 
umbilical artery Doppler abnormalities may be a sign of severe hypovolemia or they 
can be associated with selective placental insufficiency, especially in the presence of 
a large inter-twin fetal weight discordance, which in our series occurred more 
frequently for cases with abnormal donor Dopplers (Table 5). However, in this study 
the degree of fetal weight discordance did not provide an independent contribution to 
neonatal outcome when Doppler assessment was included in the prediction model. 
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This may be explained by the fact that, in the context of TTTS, it is difficult to 
distinguish between hypovolemic and hypoxemic donors with a small placental 
territory based on the preoperative ultrasound evaluation used in our study. 
We did not find any significant relationship between preoperative Doppler 
assessment of umbilical artery or ductus venosus flows of recipient twins and 
neonatal survival. Previous studies have shown that additional echocardiographic 
findings, such as cardiac hypertrophy and dilatation, atrioventricular flow 
abnormalities, increased myocardial performance index, abnormal cardiac output and 
others, can identify a group of TTTS recipients with a worsened cardiovascular 
function21-23. However, there are discordant results among the published studies on 
the value of a detailed cardiovascular assessment in the prediction of recipient 
survival24-28 and therefore, further investigation into this topic is required. 
Dual survival is the main objective of intrauterine treatment of TTTS and our data 
showed that this is strongly influenced by the presence or absence of umbilical artery 
Doppler abnormalities of donor twins. In this group, which accounted for about 30% 
of all TTTS cases in our population, dual survival was substantially lower compared 
to what was observed in the remaining pregnancies, with a similar survival of at least 
one twin between the two groups (Table 5). Survival analysis taking into account the 
prevalence of donor Doppler abnormalities may be useful for a better understanding 
of the effects of endoscopic laser on the natural history of the donor and recipient 
diseases under different preoperative conditions and for making meaningful 
comparisons between different studies. For example, two previous series5,8 reported 
a similar survival of at least one twin, after endoscopic laser, of about 85% and 82%, 
respectively, and a wider difference in dual survival (38% and 54%, respectively) due 
to a higher donor mortality in one study5. It is likely that a major contribution to these 
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results was given by the large difference in the proportion of donors with abnormal 
umbilical artery Doppler between the two studies (84% and 33%, respectively). From 
a clinical perspective, our results may have an impact on parents’ expectations 
before laser surgery about the chance for both babies to survive but would not 
change the clinical management and the treatment choice, which has been widely 
agreed to be endoscopic laser in cases presenting with TTTS. 
One limitation of this study is the unavailability of placental injection studies, which 
could have been used to assess measures of placental sharing in relation to 
preoperative ultrasound factors. In addition, we did not report data on postnatal 
neurological morbidity, which requires a longer follow-up period.  
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Table 1. Obstetric and fetal preoperative characteristics of the study population. 
 
 N=106 
Obstetric characteristics  
  Gestational age at laser (weeks) 19.7 (15.1-27.6) 
  Cervical length (mm) 34.5 (12-45) 
  Placenta location  
    Anterior 51 (48.1) 
    Posterior 55 (51.9) 
  
Fetal characteristics  
  Estimated fetal weight (g)  
    Donor 232 (112-992) 
    Recipient 316 (145-1176) 
  EFWD > 25%  45 (42.5) 
  Donor smaller than recipient 105 (99.1) 
  Umbilical artery absent or reversed EDV  
    Donor 35 (33.0) 
    Recipient 2 (1.9) 
  Ductus venosus absent or reversed a-wave  
    Donor 9 (8.5) 
    Recipient 20 (18.9) 
  Quintero stage  
    I 27 (25.5) 
    II 27 (25.5) 
    III 51 (48.1) 
    IV 1 (0.9) 
Numbers are presented as median (range) or n (%). 
EFWD = estimated fetal weight discordance; EDV = end-diastolic velocity 
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Table 2. Details on pregnancy and neonatal outcomes of the study population. 
 
 N=106 
Pregnancy outcome  
  Gestational age at delivery (weeks) 30.6 (16.3-40.3) 
  Delivery < 24 weeks 16 (15.1) 
  Delivery 24-28 weeks 17 (16.0) 
  Delivery 29-32 weeks 40 (37.8) 
  Delivery >32 weeks 33 (31.1) 
  
Neonatal outcome  
  Dual survival 60 (56.6) 
  At least 1 survivor 88 (83.0) 
  Individual twin survival  
    Donor 68 (64.2) 
    Recipient 80 (75.5)* 
  Birthweight of live births (g)  
    Donor 1399 (490-2460) 
    Recipient 1600 (530-3320)* 
  
Causes of twin loss  
  Intrauterine death  
    Donor 25 (23.6) 
    Recipient 11 (10.4)* 
  PROM < 24 wks - Miscarriage 9 (8.5) 
  Selective fetocide 5 (4.7) 
  Neonatal death 4 (3.8) 
Numbers are presented as median (range) or n (%). 
* P<0.05 compared to donor co-twins 
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Table 3. Preoperative findings in donor and recipient fetuses that survived compared to those that died. 
 
 Donor fetus   Recipient fetus   
 Alive (n=68) Demise (n=38) P-value Alive (n=80) Demise (n=26) P-value 
Obstetric factors       
  Gestational age at laser (weeks) 20.2 (16.3-27.6) 18.9 (15.1-26.3) 0.140 19.4 (15.0-26.9) 20.1 (15.7-27.6) 0.665 
  Cervical length (mm) 35.0 (18-45) 33 (12-41) 0.263 35.0 (12-45) 33.0 (16-40) 0.268 
  Anterior placenta 34 (50.0) 21 (55.3) 0.687 45 (56.3) 10 (38.5) 0.175 
       
Fetal factors       
  EFWD > 25% 23 (33.8) 22 (57.9) 0.024 31 (38.8) 14 (53.8) 0.253 
  Donor UA absent or reversed EDV 14 (20.6) 21 (55.3) <0.01 25 (31.3) 10 (38.5) 0.632 
  Donor DV absent or reversed a-wave 3 (4.4) 6 (15.8) 0.067 5 (6.3) 4 (15.4) 0.218 
  Donor visible bladder 31 (45.6) 16 (42.1) 0.839 43 (53.8) 16 (61.5) 0.507 
  Recipient UA absent or reversed EDV 1 (1.5) 1 (2.6) 1 1 (1.3) 1 (3.8) 0.432 
  Recipient DV absent or reversed a-wave 12 (17.6) 8 (21.1) 0.796 12 (15.0) 8 (30.8) 0.088 
Numbers are presented as median (range) or n (%).  
EFWD = estimated fetal weight discordance; UA = umbilical artery; DV = ductus venosus; EDV = end-diastolic velocity 
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Table 4. Logistic regression analysis for predicting donor survival after equatorial laser based on preoperative findings. 
Variable 
Univariate analysis Multivariate analysis 
OR 95% CI P-value OR 95% CI P-value 
Gestational age at laser (weeks) 1.151 0.994 – 1.334 0.061 - - - 
Cervical length (mm) 1.033 0.963 – 1.108 0.369 - - - 
Anterior placenta 0.810 0.365 – 1.796 0.603 - - - 
EFWD > 25% 0.372 0.164 – 0.841 0.018 - - - 
Visible bladder 0.868 0.389 – 1.935 0.729 - - - 
Donor UA absent or reversed EDV 0.210 0.088 – 0.500 <0.001 0.249 0.101 – 0.610 0.002 
Donor DV absent or reversed a-wave 0.246 0.058 – 1.048 0.058 - - - 
EFWD = estimated fetal weight discordance; UA = umbilical artery; DV = ductus venosus; EDV = end-diastolic velocity; OR = odds ratio; CI = confidence 
interval
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Table 5. Obstetric and fetal characteristics, neonatal outcome and causes of twin loss in 
TTTS cases with absent or reversed end diastolic velocity in the umbilical artery of the donor 
(Group A) compared to the remainder pregnancies (Group B). 
 
 
Group A 
n=35 
Group B 
n=71 
P-value 
Obstetric characteristics    
  Gestational age at laser (weeks) 19.4 (15.1-26.7) 20.0 (16.1-27.6) 0.161 
  Cervical length (mm) 34.0 (20-41) 35.0 (12-45) 0.988 
  Gestational age at delivery (weeks) 29.9 (16.3-40.3) 31.3 (16.3-38.3) 0.367 
    
Fetal characteristics    
  EFWD > 25% 22 (62.9) 23 (32.4) <0.01 
  Recipient UA absent or reversed EDV 2 (5.7) 0 0.107 
  Recipient DV absent or reversed a-wave 5 (14.3) 15 (21.1) 0.443 
    
Neonatal outcome    
  Dual survival 14 (40.0) 46 (64.8) 0.02 
  At least 1 survivor 25 (71.4) 63 (88.7) 0.06 
  Individual twin survival    
    Donor 14 (40.0) 54 (76.1) <0.01 
    Recipient 25 (71.4) 55 (77.5) 0.632 
    
Causes of twin loss    
  Intrauterine death    
    Donor 15 (42.9) 10 (14.1) 0.02 
    Recipient 3 (8.6) 8 (11.3) 1 
  PROM < 24 wks - Miscarriage 5 (14.3) 4 (5.6) 0.153 
  Selective fetocide 1 (2.9) 4 (5.6) 1 
  Neonatal death 1 (2.9) 3 (4.2) 1 
Numbers are presented as median (range) or n (%). 
EFWD = estimated fetal weight discordance; EDV = end-diastolic velocity 
